Nicole Tran, MD
Cardiovascular Disease · Oklahoma City, OKNPI 1164683405
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,364 of the $2,942 with a category attached, or 80.4%. GE HealthCare accounts for 61.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $1,814 and has fallen 97.9% since, to $38 in 2024. That places this record below the midpoint for cardiovascular disease clinicians in OK, where the typical reported total is $2,806.
Across 21 payments — averaging $140.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$2K
- Ancora Heart, Inc.$778
- Heartflow, Inc.$100
- Boehringer Ingelheim$54
- Amgen$52
- Sanofi-aventis U.S. LLC$40
- plus $108 from 5 others
What the payments were for
- Travel & lodging$2,36480%
- Food & beverage$57820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 4 | $1,811 |
| Ancora Heart, Inc. | 4 | $778 |
| Heartflow, Inc. | 1 | $100 |
| Boehringer Ingelheim | 3 | $54 |
| Amgen | 2 | $52 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Johnson & Johnson | 1 | $28 |
| Abbott | 1 | $25 |
| Vifor Pharma, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Edwards Lifesciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$100
How this compares
$2,942 in reported general payments places this provider in the 50th percentile of 164 cardiovascular disease providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nadolol | 126 | $311 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Oklahoma City
- Aly El BanayosyOklahoma City$54K
- Dwight ReynoldsOklahoma City$47K
- Udho ThadaniOklahoma City$41K
- Robert SullivanOklahoma City$36K
- Reji PappyOklahoma City$25K
- Sandeep ChopraOklahoma City$15K
- Jered CookOklahoma City$14K
- William CollazoOklahoma City$11K
- Vinodh JeevananthamOklahoma City$11K
- Niraj PrasadOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.